Listar por autor "MacDonald, Peter"

Mostrando ítems 1-2 de 2

    • Assessing the relationship between molecular rejection and parenchymal injury in heart transplant biopsies 

      Madill-Thomsen, Katelynn S.; Reeve, Jeff; Aliabadi-Zuckermann, Arezu; Cadeiras, Martin; Crespo-Leiro, María Generosa; Depasquale, Eugene D.; Deng, Mario; Goeckler, Johannes; Kim, Daniel H.; Kobashigawa, Jon; MacDonald, Peter; Potena, Luciano; Shah, Keyur; Stehlik, Josef; Zuckermann, Andreas; Halloran, Philip F. (Wolters Kluwer, 2022-11)
      [Abstract] Background: The INTERHEART study (ClinicalTrials.gov #NCT02670408) used genome-wide microarrays to detect rejection in endomyocardial biopsies; however, many heart transplants with no rejection have late dysfunction ...

    • Assessment of omecamtiv mecarbil for the treatment of patients with severe heart failure: a post hoc analysis of data from the GALACTIC-HF randomized clinical trial 

      Felker, G. Michael; Solomon, Scott D.; Claggett, Brian; Díaz, Rafael; McMurray, John J.V.; Metra, Marco; Anad, Inder; Crespo-Leiro, María Generosa; Dahlström, Ulf; Goncalvesova, Eva; Howlett, Jonathan G.; MacDonald, Peter; Parkhomenko, Alexander; Tomcsányi, János; Abbasi, Siddique A.; Heitner, Stephen B.; Hucko, Thomas; Kupfer, Stuart; Malik, Fady I.; Teerlink, John R. (American Medical Association, 2021-10-13)
      [Abstract] Importance: Heart failure with reduced ejection fraction is a progressive clinical syndrome, and many patients' condition worsen over time despite treatment. Patients with more severe disease are often intolerant ...